Translational Development Acquisition Corp. (TDAC) Income Statement
Translational Development Acquisition Corp. Income Statement
Last quarter (Q2 2026), Translational Development Acquisition Corp.'s total revenue was $0.00. In Q2, Translational Development Acquisition Corp.'s net income was $946.98K. See Translational Development Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 944.54K | $ 196.36K | $ 485.55K | $ 70.66K | $ -1.39M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 70.66K | $ 359.61K |
| $ -944.54K | $ -196.36K | $ -485.55K | $ 0.00 | $ -1.03M | |
| $ -944.54K | $ -196.36K | $ -485.55K | $ -70.66K | $ -1.39M | |
| $ 7.31M | $ 125.35K | $ 0.00 | $ 0.00 | $ 359.61K | |
| $ 6.36M | $ -71.01K | $ -485.55K | $ -70.66K | $ -1.03M | |
| $ 6.36M | $ -71.01K | $ -485.55K | $ -70.66K | $ -809.05K | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.37 | $ -0.02 | $ -0.03 | $ -0.02 | $ -0.11 |
| Diluted EPS | $ 0.37 | $ -0.02 | $ -0.03 | $ -0.02 | $ -0.11 |
| Weighted Average Shares Outstanding | 17.25M | 4.39M | 19.05M | 4.05M | 7.29M |
| Weighted Average Shares Outstanding (Diluted) | 17.25M | 4.39M | 19.05M | 4.05M | 7.29M |
Currency in USD
